Veterinary has been protagonist for ASAlaser during the last year: the growth of the revenue compared to 2012 (20%) has gone hand in hand with the adoption of MLS® Laser Therapy from prestigious international hospitals and Vet clinics (Firth Veterinary Hospital in London, Amherst Veterinary Hospital in Vancouver, Doxie Animal Hospital in Mississauga, among others). The participation of ASAveterinary at important fairs in America as in Europe - Agroexpo in Bogota, VetMadrid, Congress Veterinário Montenegro Hospital in Portugal - and the organization of training days and webinars in Italy and abroad have confirmed the progress of the sector. «If USA and Nordic Countries - says Lucio Zaghetto, ASAlaser CEO - have been first movers, thanks to their strong tradition in the use of laser therapy in veterinary field, new markets, including Brazil and Germany, are showing interest in distribute MLS® as therapeutic proposal». Devices that have been a focus for the year just ended. During Medica 2013 the Company’s stand has dedicated for the first time a special corner to veterinary with an important preview: a new version of the veterinary device (Mphi Vet Orange) with specific protocols. «The official presentation of the new line Mphi Vet ORANGE - continues Zaghetto - has opened our 2014 in America: during NAVC, a prestigious meeting of the vet community, we were able to explore the new therapeutic proposal that allows us to lead the market». The innovative techniques adopted together with the scientific evidence as result of research at the cellular level and clinical outcomes support ASAlaser in this new challenge. Research, innovation, internationalization are some of the pillars on which will be based the futute of ASAveterinary that, for 2014, looks abroad with enthusiasm.
